Citi Appointed as Depositary Bank for Abivax SA’s ADR Program
- Citi's appointment as depositary bank could increase Abivax's investor outreach and expand its global equity distribution network.
- None.
Abivax’s ADSs trade on the Nasdaq Global Market under the ticker symbol “ABVX”. The company’s underlying ordinary shares are listed on Euronext Paris under the symbol “ABVX”. Each ADS represents one ordinary share of the company.
Commenting on the appointment, Dirk Jones, Global Head of Issuer Services, at Citi said: “We look forward to supporting Abivax’s ADR program and expanding the company’s investor outreach through the expertise of our Investor Relations Advisory team and the breadth of our global equity distribution network.”
Citi is a leading provider of depositary receipt services. With depositary receipt programs in 67 markets, spanning equity and fixed-income products, Citi leverages its global network to provide cross-border capital market access to issuers, intermediaries, and investors.
For more information on Citi’s Depositary Receipt Services, visit www.citi.com/dr .
About Abivax
Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
For more information on Abivax, visit https://www.abivax.com/.
About Citi
Citi is a preeminent banking partner for institutions with cross-border needs, a global leader in wealth management and a valued personal bank in its home market of
Additional information may be found at www.citigroup.com | Twitter: @Citi | LinkedIn: www.linkedin.com/company/citi | YouTube: www.youtube.com/citi | Facebook: www.facebook.com/citi
View source version on businesswire.com: https://www.businesswire.com/news/home/20231026532504/en/
Citi Media Contacts:
Richard Bicknell
+44 (0) 20 7500 5003
richard.bicknell@citi.com
Source: Citi
FAQ
Who has been appointed as the depositary bank for Abivax's IPO?
Where do Abivax's ADSs trade?
Where are Abivax's ordinary shares listed?